Neurosciences articles for Switzerland

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 101

Article ‘Count’ for Neurosciences.

Journal Count Share
10 3.68
Speech Biomarkers for Quantifying Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease 0.83
Auditory Stimulation of Slow‐Wave Sleep Promotes Recovery after Brain Injury in an Animal Model 0.90
Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy 0.03
Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel Occlusion 0.09
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale 0.06
<atl>Effects of Intradural Extension of Extracranial Cervical Artery Dissection on Outcomes: A Secondary Analysis From the scpSTOP/scp ‐ scpCAD/scp Study</atl> 0.13
Thrombectomy versus Medical Management for Pediatric Acute Ischemic Stroke Due to Isolated M2 Occlusion: A Multicenter Cohort Study 0.19
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study 0.41
Cuneiform Nucleus Stimulation Can Assist Gait Training to Promote Locomotor Recovery in Individuals With Incomplete Tetraplegia 1.00
Subthalamic Electrophysiological Mapping of Gait Initiation Dynamics and Freezing in Parkinson's Disease 0.04
1 0.09
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment 0.09
4 0.87
Spatial propagation of movement-related basal ganglia activity predicts parkinsonian motor state 0.78
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study 0.04
Associations between epilepsy-related polygenic risk and brain morphology in childhood 0.03
Brain atrophy patterns in anti-IgLON5 disease 0.03
3 1.36
Myelin antigen capture in the CNS by B cells expressing EBV latent membrane protein 1 leads to demyelinating lesion formation 0.89
A glycolytic shunt via the pentose phosphate pathway is a metabolic checkpoint for nervous system sensory homeostasis and axonal regeneration 0.05
Astrocytes functionally integrate multiple synapses via specialized leaflet domains 0.42
1 0.56
Structural insights into copper and zinc binding to tau protein and the impact of metal binding on amyloid aggregation 0.56
1 0.11
Herpes Simplex Virus Type 1 Encephalitis: A Prospective Population-Based Cohort Study 0.11
1 0.89
Sex Disparities in the Clinical Management and Outcomes of Critically Ill Adults Undergoing Electroencephalography Monitoring. 0.89
1 0.12
Sensory neurons shape local macrophage identity via TGF-β signaling 0.12
1 0.02
Intracranial Pressure Treatment Thresholds in Pediatric Traumatic Brain Injury 0.02
1 0.01
Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis 0.01
2 0.96
Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke 0.02
Levodopa Added to Stroke Rehabilitation 0.95
1 1.00
In situ metabolomics reveals intra-islet metabolite changes upon in vivo stimulation of insulin secretion 1.00
2 1.22
Dynamic alterations of dural and bone marrow B cells in an animal model of progressive multiple sclerosis 0.22
Oligodendrocyte-derived IL-33 regulates self-reactive CD8+ T cells in CNS autoimmunity 1.00
2 1.82
Transcutaneous auricular vagus nerve stimulation during movement selectively activates motor circuitry without additional cortical or autonomic effects 0.88
Stable Mechanoreceptive Somatotopy in Chronic Low Back Pain: Is Cortical Map Reorganization a Myth? 0.94
3 0.44
Mechanisms reducing parasympathetic activity in chronic hypoxia 0.05
Lactate potentiates NMDA receptor currents via an intracellular redox mechanism targeting GluN2B subunits: implications for synaptic plasticity 0.14
The role of acid-base balance in cerebrovascular and ventilatory responses to CO2 during 10 h normobaric hypoxia 0.25
1 0.07
Femtosecond Soft X-ray Absorption Spectroscopy Identifies Metal-Centered S1 Excited State of Cyanocobalamin 0.07
2 1.90
Gesture deficits in psychosis and the combination of group psychotherapy and transcranial magnetic stimulation: A randomized clinical trial 0.90
Mapping symptom-general and symptom-specific targets for transcranial magnetic stimulation in schizophrenia: an electric-field modeling meta-analysis 1.00
3 0.35
Astrocytes connect specific brain regions through plastic networks 0.08
Intestinal macrophages modulate synucleinopathy along the gut–brain axis 0.07
Synthetic α-synuclein fibrils replicate in mice causing MSA-like pathology 0.20
18 9.03
Ultrastructural diversity and subcellular organization of nigral Lewy pathology in Parkinson’s disease 0.77
Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse model 0.88
Astroglial disinhibition of cortical circuits disrupts cognition via kynurenic acid in mice 0.88
In vivo imaging of central nervous system fluid spaces using synchrotron radiation-based micro computed tomography 0.68
Neurons of the human subthalamic nucleus engage with local delta frequency processes during action cancellation 0.02
Distinct modes of dopamine modulation on striatopallidal synaptic transmission 0.13
Descending inhibitory rostral ventromedial medulla neurons cause widespread antinociception and contribute to the pain-inhibits-pain phenomenon 0.77
TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation 0.12
Alzheimer’s Aβ catalyzes Tau phase separation and aggregation via early nanocluster solubilization 0.75
Prime editing of the β adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer’s disease 0.89
Personalized biomarkers of multiscale functional alterations in temporal lobe epilepsy 0.04
Age modulates the link between stress-related neural activity and mortality 0.92
Development of [F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology 0.81
In vivo imaging of the barrier properties of the glia limitans during health and neuroinflammation 1.00
Synthetic chaperone based on Hsp90-Tau interaction inhibits Tau aggregation and rescues physiological Tau-Microtubule interaction 0.06
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson’s disease 0.14
Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease 0.13
Cell-specific mechanisms drive connectivity across the time course of Huntington’s disease 0.03
1 0.01
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis 0.01
1 0.09
A transcriptomic microglia taxonomy across mouse and human pathologies 0.09
9 2.01
Activity-dependent adaptive deep brain stimulation improves gait in Parkinson’s disease 1.00
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism 0.03
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial 0.06
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 0.02
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial 0.05
Oral splicing modulator branaplam in Huntington’s disease: a phase 2 randomized controlled trial 0.38
Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial 0.04
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial 0.06
AI-driven reclassification of multiple sclerosis progression 0.39
6 0.55
Aberrant tau accumulation caused by mutations induces early pathological changes in axonal transport that are rescued by p38α inhibition 0.06
Foamy microglia link oxylipins to disease progression in multiple sclerosis 0.18
Sleep-dependent infraslow rhythms are evolutionarily conserved across reptiles and mammals 0.10
Impaired capillary–venous drainage contributes to gliosis and demyelination in mouse white matter during aging 0.08
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.03
Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer’s disease 0.10
3 1.73
Intrinsic endothelial remodeling drives brain capillary repair 0.74
Alzheimer’s disease pathology degrades an NMDA receptor-dependent spontaneous activity pattern in cortico-hippocampal circuits 0.04
Neurons undergo IFNγ-driven persistent epigenetic shifts and synaptopathy in encephalitis 0.95
3 1.09
Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity 1.00
Sleep deprivation and sleep intensity exert distinct effects on cerebral vasomotion and brain pulsations driven by the respiratory and cardiac cycles 0.04
Combining gamma neuromodulation and robotic rehabilitation after a stroke restores parvalbumin interneuron dynamics and improves motor recovery in mice 0.05
3 0.89
Restoring the interplay between the endoplasmic reticulum and mitochondria by gene therapy improves Charcot–Marie–Tooth type 2A disease 0.07
Preservation of anticorrelated brain networks predicts recovery after traumatic brain injury 0.10
Higher-order interactions in neuronal function: From genes to ionic currents in biophysical models 0.71
1 0.04
Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes 0.04
1 0.11
Structure of the Huntingtin F-actin complex reveals its role in cytoskeleton organization 0.11
5 1.54
Skin thermal dynamics and hypothalamic thermosensitivity dissociate REM sleep and cataplexy in narcolepsy 0.73
Brain-derived tau for monitoring brain injury in acute ischemic stroke 0.07
Reconnecting the vagus nerve to the heart through nerve conduit preserves cardiac function in a minipig model of right cardiac vagotomy 0.02
Immune signatures link myelin oligodendrocyte glycoprotein antibody–associated disease to other autoantibody-mediated conditions 0.66
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis 0.07
2 0.13
Direct interaction between TDP-43 and Tau promotes their co-condensation, while suppressing Tau fibril formation and seeding 0.10
Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2 0.04
1 0.06
Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial 0.06
5 0.68
Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial 0.29
Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study 0.06
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1 Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial 0.05
Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case–control study 0.24
Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis 0.05
2 0.25
Asundexian for Secondary Stroke Prevention 0.02
Risdiplam in Presymptomatic Spinal Muscular Atrophy 0.23

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.